Stockscreener 앱 받기
12.93
0.19%
-0.025
전일 마감가:
$12.95
열려 있는:
$12.33
하루 거래량:
300
Relative Volume:
0.06
시가총액:
$103.41M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-4.26%
1개월 성능:
+4.23%
6개월 성능:
+18.58%
1년 성능:
+0.00%
1일 변동 폭
$12.33
$12.33
1주일 범위
$12.33
$14.00
52주 변동 폭
$8.86
$22.63
Exozymes Inc Stock (EXOZ) Company Profile
명칭
Exozymes Inc
전화
(626) - 415 - 1488
주소
750 ROYAL OAKS DR, MONROVIA
EXOZ을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EXOZ
Exozymes Inc
|
12.33 | 108.61M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.60 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.79 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.54 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.70 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.41 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Exozymes Inc 주식(EXOZ)의 최신 뉴스
Real time pattern detection on eXoZymes Inc. stockExit Point & Momentum Based Trading Ideas - newser.com
eXoZymes Inc. stock trendline breakdownJuly 2025 Fed Impact & Safe Swing Trade Setup Alerts - newser.com
eXoZymes Inc.’s volatility index tracking explainedMarket Sentiment Review & Fast Gain Stock Trading Tips - newser.com
Is eXoZymes Inc. stock entering bullish territoryWeekly Investment Summary & Growth Oriented Trade Recommendations - newser.com
eXoZymes (NASDAQ:EXOZ) Receives “Sell (E+)” Rating from Weiss Ratings - Defense World
Relative strength of eXoZymes Inc. in sector analysisQuarterly Profit Report & Free Real-Time Volume Trigger Notifications - newser.com
Full technical analysis of eXoZymes Inc. stockJuly 2025 Fed Impact & Real-Time Market Trend Scan - newser.com
What high frequency data says about eXoZymes Inc.Inflation Watch & Weekly Momentum Stock Picks - newser.com
eXoZymes Unveils Updated Investor Presentation - TipRanks
Why analysts upgrade eXoZymes Inc. stockMarket Growth Report & Daily Volume Surge Signals - newser.com
Driving the Cell-Free Revolution: eXoZymes Leaders Join BioMADE Leadership & Technical Committees - ACCESS Newswire
Cell-Free Biomanufacturing Pioneer eXoZymes Gains Strategic Positions in Federal Innovation Institute - Stock Titan
What analysts say about eXoZymes Inc stockVolatility Adjusted Trading & Free Robust Financial Gains - earlytimes.in
HCM II Acquisition Corp Stock Analysis and ForecastStock Price Divergence & Low Risk Wealth Building - earlytimes.in
Multi asset correlation models including Walgreens Boots Alliance Inc.2025 Trading Volume Trends & Growth-Oriented Investment Plans - newser.com
How hedge fund analytics apply to RDDT stock2025 Retail Activity & Daily Momentum Trading Reports - newser.com
Why Encres Dubuit (1F2) stock is a strong buy callStop Loss & Fast Momentum Entry Tips - newser.com
Why National Bank of Canada (NBC) stock could be next leaderPortfolio Gains Summary & Target Return Focused Stock Picks - newser.com
Can FTI Consulting Inc. (FCQ) stock surprise with quarterly resultsWeekly Trade Report & Weekly Breakout Watchlists - newser.com
Is Ponsse Oyj (PNS) stock a buy before earnings resultsLayoff News & Growth Focused Stock Reports - newser.com
Is Roman DBDR Acquisition Corp. II Equity Warrant stock a buy on dipsJuly 2025 Intraday Action & Daily Entry Point Alerts - newser.com
Is Owlet Inc. stock a good choice for value investorsSell Signal & Safe Entry Trade Reports - newser.com
Is MGR stock supported by free cash flow2025 Retail Activity & Low Drawdown Investment Strategies - newser.com
How to recover losses in Falcon s Beyond Global Inc. stockJuly 2025 Update & Low Drawdown Trading Techniques - newser.com
Will HAL Trust (HA4) stock benefit from Fed rate cutsQuarterly Profit Review & Short-Term High Return Strategies - newser.com
Why Tradeweb Markets Inc. stock attracts high net worth investorsJuly 2025 Price Swings & High Conviction Trade Alerts - newser.com
Is ITOCHU Corporation (IOC) stock bottoming after sell offBuy Signal & Fast Moving Stock Watchlists - newser.com
Why China Resources Pharmaceutical Group Limited (640) stock is a strong analyst pickMarket Weekly Review & Free High Accuracy Swing Entry Alerts - newser.com
Is eXoZymes Inc a good long term investmentInsider Selling Patterns & High Yield Trading Alerts - Early Times
D pipelineTrade Entry Summary & Proven Capital Preservation Methods - newser.com
Is ARLU stock attractive for dividend growth2025 Market Trends & Detailed Earnings Play Strategies - newser.com
HEICO Corporation stock volume spike explainedWeekly Gains Summary & Growth Oriented Trading Recommendations - newser.com
How high can eXoZymes Inc. stock goJuly 2025 Market Mood & Low Drawdown Momentum Ideas - newser.com
Exozymes Inc (EXOZ) 재무 분석
Exozymes Inc (EXOZ)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Exozymes Inc 주식 (EXOZ) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Heltzen Michael | Chief Executive Officer |
Jan 17 '25 |
Buy |
10.78 |
1,767 |
19,048 |
3,872 |
| Heltzen Michael | Chief Executive Officer |
Jan 16 '25 |
Buy |
10.72 |
121 |
1,297 |
2,105 |
| Heltzen Michael | Chief Executive Officer |
Nov 15 '24 |
Buy |
11.10 |
1,984 |
22,022 |
1,984 |
1.24%
자본화:
|
볼륨(24시간):